Zobrazeno 1 - 10
of 211
pro vyhledávání: '"drug hypersensitivity reaction"'
Autor:
Rasol Molatefi, Sedighe Talebi, Azam Samei, Neda Roshanravan, Shirin Manshouri, Baran Hashemi, Vahid Ghobadi Dana, Erfan Mosharkesh, Mohammad Ali Bahar, Sholeh Khajoei, Farhad Seif
Publikováno v:
Heliyon, Vol 10, Iss 14, Pp e33976- (2024)
Drug hypersensitivities are common reactions due to immunologic responses. They are of utmost importance because they may generate severe and fatal outcomes. Some drugs may cause Adverse Drug Reactions (ADRs), such as drug hypersensitivity reactions
Externí odkaz:
https://doaj.org/article/ac8e50136cb0429d96a15b888c0f88d9
Autor:
Gustavo-Jorge Molina-Molina, MD, Manuel Gómez-Duque, MD, Xavier Vidal Guitart, MD, PhD, Antònia Agustí Escasany, MD, PhD, Moisés Labrador-Horrillo, MD, PhD, Olga Luengo, MD, PhD, Anna Sala-Cunill, Paula Galvan-Blasco, MD, Mar Guilarte, MD, PhD, Victoria Cardona, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 6, Pp 100914- (2024)
Background: Drug provocation tests (DPT) are considered the gold standard procedure to ascertain the diagnosis of beta-lactam (BL) allergy. Regarding route of administration, current recommendations prioritize oral challenges, considering them safer,
Externí odkaz:
https://doaj.org/article/e3a02a31a0cc4f0a81fa3f4e4c8b44e7
Autor:
Joelle Dagher, PharmD, PhD, Diane Antonios, PharmD, PhD, Sylvie Chollet-Martin, PharmD, PhD, Luc de Chaisemartin, PharmD, PhD, Marc Pallardy, PharmD, PhD, Hayat Azouri, PharmD, PhD, Carla Irani, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 1, Pp 100169- (2024)
Background: Drug hypersensitivity reactions (DHRs) are becoming more common as a result of increasing prevalence and case complexity. Allergists and clinical immunologists worldwide are challenged daily to adequately diagnose and manage these reactio
Externí odkaz:
https://doaj.org/article/54cd25a260b04124951f5f9251b6f7ee
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P C Kathuria, Manisha Rai
Publikováno v:
Indian Journal of Allergy Asthma and Immunology, Vol 36, Iss 1, Pp 4-17 (2022)
The new classification of drug hypersensitivity reactions (DHRs) is based on phenotypes, endotypes, and biomarkers. Immediate and delayed reactions are the clinical phenotypic presentation while endotypes are based on cellular, biological mediators,
Externí odkaz:
https://doaj.org/article/11a912eb3f304e7f8c4ee00bd011f8a9
Publikováno v:
Frontiers in Allergy, Vol 3 (2023)
BackgroundDrug hypersensitivity reactions (DHRs) are major medical problems that influence the treatment of patients by both under- and overdiagnosis. Still, little is known about the role of predisposing or protecting cofactors of DHR.ObjectiveThis
Externí odkaz:
https://doaj.org/article/d0b5bc605ea244dbbbfad742a547bfff
Autor:
Fan Yang, Nathachit Limjunyawong, Qi Peng, John T. Schroeder, Sarbjit Saini, Donald MacGlashan, Xinzhong Dong, Li Gao
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundAllergic drug reaction or drug allergy is an immunologically mediated drug hypersensitivity reaction (DHR). G-protein coupled receptors (GPCRs) are common drug targets and communicate extracellular signals that initiate cellular responses.
Externí odkaz:
https://doaj.org/article/4c6b9ed6863f4640bdf780a39e9ea612
Autor:
Witchaya Srisuwatchari, MD, Tram Vo, MD, Amélie Gauthier, MD, Nicolas Molinari, PhD, Rik Schrijvers, MD, PhD, Pascal Demoly, MD, PhD, Anca Mirela Chiriac, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 9, Pp 100680- (2022)
Background: Drug hypersensitivity reaction (DHR) to iodinated radiocontrast media (iRCM) is reported in 1%–3% of injections. Risk assessment of patients with suspicion of DHR to iRCM relies solely on clinical phenotyping and drug allergy workup. Us
Externí odkaz:
https://doaj.org/article/e370746754ee4d378c9953b05301e390
Evaluation of hypersensitivity reactions with leuprolide acetate and triptorelin acetate in children
Autor:
Azize Pınar Metbulut, Keziban Toksoy Adıgüzel, Candan İslamoğlu, Mehmet Boyraz, Emine Dibek Mısırlıoğlu
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 25, Iss 6, Pp 527-531 (2021)
Introduction: Gonadotropin releasing hormone analogues (GnRHa) are commonly used to treat central precocious puberty (CPP). Generally, they are well-tolerated; however adverse reactions have been reported. Local adverse events occur in 10-15% of the
Externí odkaz:
https://doaj.org/article/fc5928c3b083434f93f17730fcb5159b
Autor:
A. Piccorossi, G. Liccioli, S. Barni, L. Sarti, M. Giovannini, A. Verrotti, E. Novembre, F. Mori
Publikováno v:
Italian Journal of Pediatrics, Vol 46, Iss 1, Pp 1-13 (2020)
Abstract Background and objective Drug Hypersensitivity Reactions (DHRs) are considered adverse effects of medications that resemble allergy symptoms. The reported positive clinical history of pediatric drug reactions is about 10%, however, after all
Externí odkaz:
https://doaj.org/article/1ca6d86e72cf4b3a8ca480ddf6107531